My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Greenwich LifeSciences, Inc. - Common stock (NQ:GLSI)

10.00 +0.05 (+0.50%)
Streaming Delayed Price Updated: 9:34 AM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Greenwich LifeSciences, Inc. - Common stock

< Previous 1 2 3 4 Next >
10 Short Squeeze Candidates That May Soar: Athersys, TDH Holdings, FaZe Holdings, Weber And More
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week... 
Via Benzinga
MICS, REV: The Top 5 Short Squeeze Stocks to Watch This Week
Investors looking for the most likely short squeeze stocks to watch this week are in the right place with a list of the top five to watch! 
Via InvestorPlace
Revlon Climbs, Singing Machine Moves Up And Weber Makes Big Move: 5 Short Squeeze Stocks That May Soar This Week
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. 
Via Benzinga
Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial
From Greenwich LifeSciences, Inc.
Via Business Wire
7 Short-Term Stocks to Buy for a Quick Profit
Although the market has been volatile this year, the wildness also creates opportunities for short-term stocks to buy for a quick profit. 
Via InvestorPlace
5 Short Squeeze Stocks That May Soar Plus 5 To Watch: ToughBuilt, Redbox, Revlon And More
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. 
Via Benzinga
Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Provides Financing Strategy & Corporate Update
From Greenwich LifeSciences, Inc.
Via Business Wire
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
Via Benzinga
This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket
Gainers 
Via Benzinga
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share. 
Via Benzinga
Crude Oil Prices Fall Sharply; Greenwich LifeSciences Shares Spike Higher
U.S. stocks traded mixed toward the end of trading after recording losses in the previous session. 
Via Benzinga
Here's Why Greenwich Lifesciences Shares Are Popping Off Today
Greenwich Lifesciences Inc (NASDAQ: GLSI) shares are trading higher by 32.95% to $11.46 Tuesday afternoon after the FDA removed the clinical hold on the company's Flamingo-01 Phase 3 trial of GP2. 
Via Benzinga
U.S. Stocks Turn Higher; PepsiCo Posts Upbeat Q2 Results
U.S. stocks turned higher midway through trading after recording losses in the previous session. 
Via Benzinga
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Versus Systems (VS) Stock Roars After Nasdaq Warning
Versus Systems (VS) stock is rising higher on Tuesday after getting a delisting warning from the Nasdaq Exchange about a month ago. 
Via InvestorPlace
Why Is Greenwich Lifesciences (GLSI) Stock Up Today?
Greenwich Lifesciences (GLSI) stock is heading higher on Tuesday after the FDA lifted a hold on a Phase III clinical trial. 
Via InvestorPlace
Why Markets Are Trading Mixed; US Small Business Optimism Tumbles To This Level
U.S. stocks traded mixed this morning after recording losses in the previous session. 
Via Benzinga
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Announces Suspension of Share Repurchase Program
From Greenwich LifeSciences, Inc.
Via Business Wire
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
Greenwich LifeSciences to Resume Stock Repurchase Program
From Greenwich LifeSciences, Inc.
Via Business Wire
91 Biggest Movers From Friday
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. 
Via Benzinga
69 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday. 
Via Benzinga
Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial & ASCO Meeting
From Greenwich LifeSciences, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 73 stocks hit new 52-week lows. 
Via Benzinga
Greenwich LifeSciences to Participate in Upcoming Jefferies, Wainwright, ASCO and BIO International Conferences
From Greenwich LifeSciences, Inc.
Via Business Wire
Greenwich LifeSciences Presents Phase IIb Data, Published at AACR 2022, Further Supporting the Role of GP2 in Preventing Metastatic Breast Cancer
From Greenwich LifeSciences, Inc.
Via Business Wire
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.